Comparison of fluvoxamine, imipramine, and placebo in the treatment of outpatients with panic disorder

Anxiety

Volumn 2, Issue 4, 1996, Pages 192-198

  Nair, N P V ^a   Bakish, D ^b   Saxena, B ^c   Amin, M ^d   Schwartz, G ^a   West, T E G ^a  

^a MCGILL UNIVERSITY   (Canada)

^b ROYAL OTTAWA HOSPITAL   (Canada)

^c Hamilton Psychiatric Hospital   (Canada)

^d Lakeshore General Hospital   (Canada)

Author keywords

Confidence intervals; Panic attacks; Placebo controlled trial; SSRI; Tricyclic

Indexed keywords

ANXIOLYTIC AGENT; FLUVOXAMINE; IMIPRAMINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; PANIC; PERSONALITY TEST; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DOUBLE-BLIND METHOD; FEMALE; FLUVOXAMINE; HUMANS; IMIPRAMINE; MALE; MIDDLE AGED; PANIC DISORDER; PERSONALITY INVENTORY; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 0030320611     PISSN: 10709797     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1522-7154(1996)2:4<192::AID-ANXI6>3.0.CO;2-Q     Document Type: Article

References (18)

1. Claassen V (1983) Review of animal pharmacology and pharmacokinetics of fluvoxamine. Brit J Clin Pharmacol 15 [suppl 3]:349-355.
2. Den Boer JA, Westenberg HGM (1988) Effect of serotonin and noradrenaline uptake inhibitor in panic disorders: A double blind comparative study with Fluvoxamine and Maprotiline. Int Clin Psychopharmacol 3:59-74.
3. Den Boer JA, Westenberg HGM (1990) Serotonin function in the panic disorder: A double blind placebo controlled study with fluvoxamine and ritanserin. Psychopharmacology 102:85-94.
4. Den Boer JA, Westenberg HG, Kamerbeek WD, Verhoeven WM, Kahn RS (1987) The effect of serotonin uptake inhibitors in anxiety disorders: a double-blind comparison of clomipramine and fluvoxamine. Int Clin Psychopharmacol 2:21-32.
5. Derogatis LR, Lipman RS, Rickels K, Uhlenhuth EH, Covi L (1974) The Hopkins Symptom Checklist (HSCL): A Self-Report Symptom Inventory. Behav Sci 19:1-15.
6. Gloger S, Grunhaus L, Birmacher B, Troudart T (1981) Treatment of spontaneous panic attacks with clomipramine. Am J Psychiatry 138:1215-1217.
7. Guy W (1976) ECDEU Assessment Manual for Psychopharmacology. Rockville, Maryland: US Department of Health, Education and Welfare, pp 337-340.
8. Hoehn-Saric R, McLeod DR, Hipsley PA (1993) Effect of fluvoxamine on panic disorder. J Clin Psychopharmacol 13:321-326.
9. Liebowitz MR, Gorman JM (1986) Panic and anxiety disorders. In Cavenar JO (ed): Psychiatry. Vol. 1. Chap 32. Philadelphia: JB Lippincott Company, pp 1-13.
10. Marks IM, Mathews AM (1979) Brief standard self-rating for phobic patients. Behav Res & Therapy. 17:263-267.
11. Montgomery SA, Åsberg M (1979) A new depression scale designed to be sensitive to change. Brit J Psychiat 134:382-389.
12. Pecknold JC, Luthe L, Munjack D (1993) Panic factor: Outcome variable in panic disorder. J Psychiat Res 27:369-377.
13. Pecknold JC, Luthe L, Munjack D, Alexander P (1994) A double-blind, placebo-controlled, multicenter study with alprazolam and extended-release alprazolam in the treatment of panic disorder. J Clin Psychopharmacol 14:314-321.
14. Regier DA, Narrow WE, Rae DS (1990) The epidemiology of anxiety disorders: The epidemiological catchment area (ECA) experience. J Psychiatr Res 24, Suppl 2:3-14.
15. Rosenberg R (1993) Drug treatment of panic disorder. Pharmacol Toxicol 72:344-353.
16. Sheehan DV (1986) The Anxiety Disease. New York: Bantam Books.
17. Snaith RP, Baugh SJ, Clayden AD, Husain A, Sipple MA (1982) The clinical anxiety scale: An instrument derived from the Hamilton anxiety scale. Brit J Psychiat 141:518-523.
18. Zitrin CM, Klein DE, Woerner MG, Ross D (1983) Treatment of phobias I. Comparison of imipramine hydrochloride and placebo. Arch Gen Psychiatry 40:125-138.